- The Michael J. Fox Foundation grant supports the development of AC Immune’s first-in-class TDP-43 PET tracer program
- Target ALS Foundation grant supports collaboration between AC Immune and world-class institutions to accelerate the development of novel biofluid assays for detecting TDP-43-related neuropathologyA
Westlake Set To Join S&P MidCap 400, Replacing MillerKnoll; MillerKnoll To Replace Covetrus In S&P SmallCap 600
Westlake Corp. (NYSE:WLK) will replace MillerKnoll Inc. (NASD:MLKN) in the S&P MidCap 400, and MillerKnoll will replace Covetrus Inc. (NASD:CVET) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 18.